Provided by Tiger Fintech (Singapore) Pte. Ltd.

Amgen

278.23
-0.1750-0.06%
Volume:1.05M
Turnover:294.56M
Market Cap:149.59B
PE:36.80
High:283.60
Open:279.91
Low:277.13
Close:278.40
Loading ...

BUZZ-US drugmakers rise on reprieve from Trump tariffs

Reuters
·
03 Apr

Shares of US Drugmakers Rise After Tariff Exemption

THOMSON REUTERS
·
03 Apr

Shares of Abbvie up 2.5%, Johnson & Johnson up 2.5%, Merck up 1.9%, Amgen up 2.2%

THOMSON REUTERS
·
03 Apr

RBC Lifts Price Target on Amgen to $324 From $320, Keeps Outperform Rating

MT Newswires Live
·
03 Apr

Q4 Earnings Outperformers: Amgen (NASDAQ:AMGN) And The Rest Of The Therapeutics Stocks

StockStory
·
03 Apr

Bernstein Reaffirms Their Buy Rating on Amgen (AMGN)

TIPRANKS
·
03 Apr

Amgen (AMGN) Surpasses Market Returns: Some Facts Worth Knowing

Zacks
·
01 Apr

Dow's 113-Point Rally Led By Gains For Shares Of Amgen, IBM

Dow Jones
·
31 Mar

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2025-03-31

Reuters
·
31 Mar

2 Large-Cap Stocks with Solid Fundamentals and 1 to Turn Down

StockStory
·
28 Mar

Which Dow Jones Stock Is Cheaper, Amgen or Merck?

Motley Fool
·
28 Mar

Trump Weighs Tariffs on Pharma in Ireland. What It Means for Amgen, Gilead. -- Barrons.com

Dow Jones
·
27 Mar

BRIEF-Fresenius Kabi Reached A Global Settlement With Amgen Concerning Their Denosumab Biosimilars

Reuters
·
27 Mar

Fresenius Kabi: Launch of Conexxence & Bomyntra in the U.S. in Mid-2025 and in Europe Later in H2 of 2025

THOMSON REUTERS
·
27 Mar

Fresenius Kabi: Reached a Global Settlement With Amgen Concerning Their Denosumab Biosimilars

THOMSON REUTERS
·
27 Mar

VKTX Finishes Enrolment in Mid-Stage Study on Oral Weight-Loss Drug

Zacks
·
27 Mar

As Vaccine Skepticism Mounts, Moderna's Business Grows More Precarious -- Barrons.com

Dow Jones
·
27 Mar

Fresenius: Receives FDA Approval For Denosumab Biosimilars And Secures Global Settlement

Reuters
·
27 Mar

Amgen (AMGN) Receives a Buy from Piper Sandler

TIPRANKS
·
25 Mar

Amgen (AMGN) Stock Drops Despite Market Gains: Important Facts to Note

Zacks
·
25 Mar